Misinterpretation of time-to-first event curves can lead to inappropriate treatment
Benjamin Hartley, Gerard J. Criner, Mark T. Dransfield, David M.G. Halpin, MeiLan K. Han, C. Elaine Jones, Sally Kilbride, Peter Lange, David A. Lipson, David A. Lomas, Neil Martin, Fernando J. Martinez, Dave Singh, Robert A. Wise, Sally Lettis
Source: Eur Respir J, 54 (3) 1900634; 10.1183/13993003.00634-2019
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Benjamin Hartley, Gerard J. Criner, Mark T. Dransfield, David M.G. Halpin, MeiLan K. Han, C. Elaine Jones, Sally Kilbride, Peter Lange, David A. Lipson, David A. Lomas, Neil Martin, Fernando J. Martinez, Dave Singh, Robert A. Wise, Sally Lettis. Misinterpretation of time-to-first event curves can lead to inappropriate treatment. Eur Respir J, 54 (3) 1900634; 10.1183/13993003.00634-2019
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Frequent adverse events during prolonged Bedaquiline treatment on XDR-tuberculosis patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Aspirin reduces cardiovascular events in patients with pneumonia: a prior event rate ratio analysis in a large primary care database Source: Eur Respir J, 57 (2) 2002795; 10.1183/13993003.02795-2020 Year: 2021
Differences in symptoms that precede an exacerbation that influence treatment decisions Source: Annual Congress 2008 - COPD Year: 2008
Different factors have impact on severe pneumonia resolution and mortality after the initial treatment period Source: Eur Respir J 2003; 22: Suppl. 45, 150s Year: 2003
Accuracy in assessment of acute asthma needs improved to avoid potential adverse outcomes Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012
Which are the factors and causes that lead to omalizumab withdrawal in severe asthma patients? Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018
Possible erroneous classification of asthma severity as a result of non-compliance Source: Eur Respir J 2006; 28: Suppl. 50, 317s Year: 2006
Integrated care pathways significantly reduce drug dosing and administration errors in patients with acute asthma Source: Eur Respir J 2006; 28: Suppl. 50, 481s Year: 2006
Early treatment response may predict long-term mepolizumab benefit in severe asthma Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019
Predicting adverse events from pulmonary embolism (PE): does the wicki score identify patients suitable for early discharge? Source: Eur Respir J 2003; 22: Suppl. 45, 218s Year: 2003
Relationship between selected initial treatment of healthcare associated pneumonia with changing treatment,intensive care requirement, hospitalization period and death rate Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010
The risk factors of the TB death among case of initial treatment failure and retreatment after default Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012
Predictable adverse events such as respiratory depression highlight the need for caution when prescribing morphine for refractory breathlessness Source: Eur Respir J, 50 (3) 1701357; 10.1183/13993003.01357-2017 Year: 2017
Inadequate assessment of adherence to maintenance medication leads to loss of power and increased costs in trials of severe asthma therapy: results from a systematic literature review and modelling study Source: Eur Respir J, 53 (5) 1802161; 10.1183/13993003.02161-2018 Year: 2019
Does inhaled corticosteroid use affect the risk of ?COVID-19-related death? Source: Breathe, 17 (1) 200275; 10.1183/20734735.0275-2020 Year: 2021
The main causes which lead to immediate and belated failure in tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 141s Year: 2005
Prolonged anticoagulation in VTE with direct oral anticoagulants: towards an individual analysis of net clinical benefit? Source: Eur Respir J 2016; 48: 1268-1270 Year: 2016
Dose omission to shorten methacholine challenge testing: clinical consequences and safety of the use of a "10% fall in FEV1" threshold Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function Year: 2018
Faster clinical improvement and earlier discharge from hospital in CAP patients under sequential moxifloxacin treatment compared to standard therapy Source: Eur Respir J 2004; 24: Suppl. 48, 188s Year: 2004
Digital airflow measurement early in treatment course for spontaneous pneumothorax predicting surgical referral Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018